Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
10.56
+0.74 (7.54%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $3.21 billion as of October 24, 2024. Its market cap has increased by 215.49% in one year.
Market Cap
3.21B
Enterprise Value
2.65B
1-Year Change
215.49%
Ranking
Category
Stock Price
$10.56
Market Cap Chart
Since October 15, 2010, Iovance Biotherapeutics's market cap has increased from $79.00M to $3.21B, an increase of 3,957.10%. That is a compound annual growth rate of 30.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 23, 2024 | 2.98B | 43.25% |
Dec 29, 2023 | 2.08B | 106.29% |
Dec 30, 2022 | 1.01B | -66.33% |
Dec 31, 2021 | 3.00B | -55.99% |
Dec 31, 2020 | 6.81B | 94.85% |
Dec 31, 2019 | 3.49B | 220.44% |
Dec 31, 2018 | 1.09B | 87.59% |
Dec 29, 2017 | 581.10M | 34.67% |
Dec 30, 2016 | 431.50M | 16.84% |
Dec 31, 2015 | 369.30M | 69.79% |
Dec 31, 2014 | 217.50M | 9.63% |
Dec 31, 2013 | 198.40M | 1,053.49% |
Dec 31, 2012 | 17.20M | -78.23% |
Dec 30, 2011 | 79.00M | 5.05% |
Dec 31, 2010 | 75.20M | -4.81% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Amedisys | 3.18B |
Kymera Therapeutics | 3.08B |
Neogen | 3.03B |
Apogee Therapeutics | 3.03B |
PTC Therapeutics | 3.02B |
MoonLake Immunotherapeutics | 3.02B |
Rhythm Pharmaceuticals | 3.00B |
Bausch Health Companies | 2.98B |